The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Radionova E.E.

Dermatovenerological Dispensary No 15, Health Department of Eastern Administrative District, Moscow

Serov D.H.

Dermatovenerological Dispensary No 15, Health Department of Eastern Administrative District, Moscow

Vvedenskaia O.N.

Dermatovenerological Dispensary No 15, Health Department of Eastern Administrative District, Moscow

Anticytokine therapy of psoriasis

Authors:

Radionova E.E., Serov D.H., Vvedenskaia O.N.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2010;8(5): 28‑31

Read: 3074 times

Download PDF (RU)
Contact the author
Table of contents

ANTICYTOKINE THERAPY OF PSORIASIS
ANTICYTOKINE THERAPY OF PSORIASIS

To cite this article:

Radionova EE, Serov DH, Vvedenskaia ON. Anticytokine therapy of psoriasis. Russian Journal of Clinical Dermatology and Venereology. 2010;8(5):28‑31. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177
Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xero­sis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):178-184
Historical aspe­cts and prospects of psoriasis treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):284-292
Key specific tools for asse­ssment of life quality of patients with psoriasis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):319-325
Psychodermatological aspe­cts of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):403-411
New approach to clinical evaluation of nail lesions in psoriasis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):453-460
Persistence of skin process remi­ssion in patients with mode­rate and severe psoriasis vulgaris in application of neta­kimab: a five-year obse­rvational study resu­lts. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):462-468
Deve­lopment of a predictive model for the identification of patients with high risk of psoriatic arthritis and asse­ssment of the effi­cacy of early treatment with neta­kimab, IL-17A inhi­bitor. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):625-634
Unde­restimated itching symptom in psoriasis: diagnostic limi­tations and correction paths. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):675-682
Diagnostic accu­racy of the aging males’ symptoms questionnaire for screening androgen defi­ciency in patients with psoriatic arthritis. Russian Journal of Preventive Medi­cine. 2025;(5):27-33
Abstract:

A case of finger osteomyelitis and necrotic-ulcerative vasculitis is described in a patient presenting with a severe form of psoriasis and psoriatic arthritis. The patient was treated by anticytokine therapy using antibodies against tumour necrosis factor.

Keywords:

psoriasis
psoriatic arthritis
anticytokine therapy
tumour necrosis factor-alpha
infliximab

Authors:

Radionova E.E.

Dermatovenerological Dispensary No 15, Health Department of Eastern Administrative District, Moscow

Serov D.H.

Dermatovenerological Dispensary No 15, Health Department of Eastern Administrative District, Moscow

Vvedenskaia O.N.

Dermatovenerological Dispensary No 15, Health Department of Eastern Administrative District, Moscow

Close metadata

References:

  1. Braun J., Baraliakos Kh., Brand J. et al. Persistent clinical response to the anti TNF alpha antibody inflikhimab in patients with ankylosing spondylitis over 3 year. Rheumatology 2005;64:670-676.
  2. Kubanova A.A., Markusheva L.I., Fomina E.E. Uroven' syvorotochnogo faktora nekroza opukholi al'fa pri razlichnykh dermatozakh. Immunologiya 1998;2:47-49.
  3. Kurdina M.I. Antitsitokinovaya terapiya psoriaza - shag v budushchee. Farmateka 2004;7:59-65.
  4. Kiselev V.I., Lyashenko A.A. Molekulyarnye mekhanizmy regulyatsii giperplasticheskikh protsessov. M 2005.
  5. Kastelan M., Massari L., Paris A., Gruber F. New trends in the immunopathogenesis of psoriasis. Acta Dermatovenerol Croat 2004;12:1:26.
  6. Dübel S. (Hrsg.). Handbook of Therapeutic Antibodies. Vol. III, Wiley. VCH Verlag, Weinheim 2007.
  7. Jones G., Crotty M., Brooks P. Interventions for psoriatic arthritis. Cochrane Database Syst Rev 2000;2 CD000212.
  8. Gibbs A., Murray B., Radovits B. et al. Early changes in markers of bone metabolism in patients with psoriatic arthritis treated with anti-TNFβ therapy: a comparison with rheumatoid arthritis. 1th World Psoriasis and Psoriatic Arthritis Conference. Stockholm 2006; 91.
  9. Griffiths C.E. The immunological basis of psoriasis. J Eur Acad Dermatol Venereol 2003;17:Suppl 2:1-5.
  10. Nickoloff B.J., Qin J.Z., Nestle F.O. Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol 2007;3:1-2:45-56.
  11. Remikeid. Monografiya po preparatu. Shering-Plau Sentral Ist AG 2005;55.
  12. Sandra F., Degli Esposti M., Ndebele K. et al. Tumor necrosis factor-related apoptosis-including ligand alters mitochondrial memrane lipids. Cancer Res 2005;65:18:8286-8297.
  13. Mease P.J. TNFβ therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis 2004;63:755-758.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.